Holen Sie sich die Stockscreener-App
24.90
0.16%
0.04
Handel nachbörslich:
24.54
-0.36
-1.45%
Schlusskurs vom Vortag:
$24.86
Offen:
$24.78
24-Stunden-Volumen:
2.50M
Relative Volume:
1.09
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.57%
1M Leistung:
+3.06%
6M Leistung:
+5.82%
1J Leistung:
+0.12%
1-Tages-Spanne:
$24.20
$24.93
1-Wochen-Bereich:
$24.20
$25.52
52-Wochen-Spanne:
$17.50
$31.16
ARK Genomic Revolution ETF Stock (ARKG) Company Profile
Firmenname
ARK Genomic Revolution ETF
Sektor
Branche
Telefon
855-406-1506
Adresse
-
Vergleichen Sie ARKG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARKG
ARK Genomic Revolution ETF
|
24.90 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
320.14 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
649.12 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
652.21 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
253.73 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
575.23 | 124.43B | 0 | 0 | 0 | 0.00 |
ARK Genomic Revolution ETF Aktie (ARKG) Neueste Nachrichten
Cathie Wood goes biotech shopping, shells out $7.7 million - TheStreet
Your Fund Crushed. Investors Love It. Uh Oh. - Morningstar
Investment Guide to Genetics Stocks and ETFs - NAI500
Investing in the DNA of Tomorrow: Explore Gene Stocks and Genomics ETFs - Investing News Network
How to Invest in Gene Stocks and ETFs - Nasdaq
Is ARKG Still a Viable Long-Term Bet? - AInvest
ARK Genomic Revolution ETF: A Hold Rating Due to Top-Weighted Holdings' Fundamental Issues - AInvest
ARKG: I’m Holding Off Buying For These 3 Reasons (BATS:ARKG) - Seeking Alpha
ARKW: Aggressive, Highly Volatile Tech Growth Play With Bitcoin Exposure (BATS:ARKW) - Seeking Alpha
15 Funds That Have Dragged Down Portfolios for Over a Decade: What You Need to Know - Investopedia
Discounted Ozempic Could Deflate ETF Optimism Around Hims & Hers - Benzinga
Cathie Wood Trims Stakes in Robinhood, Roku, and Shopify, Adds PagerDuty and Intellia - MSN
Market month: Fund news and updates - The Globe and Mail
Cathie Wood’s ARK ETF adjusts portfolio with PagerDuty and Robinhood stock trades - Investing.com
Cathie Wood Sells Roku Stock, Doubles Down on Biotech Bets - MSN
Cathie Wood Invests $50M in Robinhood, CRISPR, and Beam Therapeutics Amid Price Dips - AInvest
Cathie Wood Snaps Up $17 Million Robinhood Stake on the Dip - Yahoo Finance
Cathie Wood Invests Heavily in Biotech Stocks Amid Market Dip - AInvest
Cathie Wood ‘Buys the Dip’ in Robinhood, CRISPR, and Beam Therapeutics Stocks - TipRanks
Ark Invest Bets Big on Robinhood’s Crypto Future - AInvest
Wisconsin Investment Board sells off 3 iShares ETFs - Pensions & Investments
ETF Daily | ETFs owned by “Female Stock Goddess” collectively broke the peak overnight, and 4 industrial marijuana ETFs rose more than 7% - 富途牛牛
Cathie Wood's Top 10 Stock Picks: Unpacking Ark Funds Innovation Picks For The Next Decade - 富途牛牛
Cathie Wood’s ARK ETFs Roar Back With Record-Breaking Inflows - ETF.com
Cathie Wood Makes a $69M Bet on Exact Sciences; Sells Palantir, Roblox, and DraftKings - MSN
Tracking Cathie Wood’s ARK Invest 13F Portfolio – Q2 2025 Update (BATS:ARKK) - Seeking Alpha
Cathie Wood ‘Buys the Dip’ in AMD Stock after Q2 Results, Cuts Roblox and Palantir (PLTR) Stakes - TipRanks
CRSP, TWST: Cathie Wood Bets Millions on Biotech, Continues Dumping Roblox - TipRanks
Cathie Wood's Ark Invest Loads Up On Coinbase, Roku, Illumina, And Bitmine Immersion - Benzinga
Unusual Option Activity: ARK Genomic Revolution ETF and Other Stocks - AInvest
Unusually active option classes on open August 1st - TipRanks
ARKG Makes Notable Cross Below Critical Moving Average - Nasdaq
CRSP, ABSI, IRDM: Cathie Wood Offloads $16.4M of CRISPR Therapeutics Stock, Buys Absci and Iridium - MSN
No record closes today in the major indices. Stocks take a breather ahead of Fed - investingLive
Palantir, Nvidia & Tempus AI: The Future of Medicine in 2025 - AInvest
Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills - Benzinga
Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics - Benzinga
TWST vs. NTRA: Which Genomics Play Is a Better Buy? - 24/7 Wall St.
ARKG: April's Wash-Out Low Is Encouraging, Healthcare Still Soft (BATS:ARKG) - Seeking Alpha
Why Cathie Wood Is Loading Up on This Hot Growth Stock (And Should You?) - inkl
Why Cathie Wood Is Loading Up On This Hot Growth Stock (And Should You?) - Barchart.com
Cathie Wood Pours Millions into Nvidia and Biotech, Dumps Rocket Lab - Yahoo Finance
Cathie Wood Boosts ILMN and NVDA Stocks, Cuts RKLB Stake Again - AInvest
Learn to Evaluate (ARKG) using the Charts - news.stocktradersdaily.com
Cathie Wood's Ark Invest Offloads Meta, Loads Up On Teradyne, Caris Life Sciences - 富途牛牛
Cathie Wood Bets Over $17M on Crypto and AI Stocks, 7/17/2025 - TipRanks
Cathie Wood's Ethereum Double-Down: Ark Bets $7.9… - inkl
Cathie Wood's Ethereum Double-Down: Ark Bets $7.9 Million On ETH-Staking ETF Buy While Selling Coinbase At Highs - Benzinga
US stocks close mixed, but near the lows for the day - Forexlive | Forex News, Technical Analysis & Trading Tools
ROKU, ACHR: Cathie Wood Offloads Millions in Roku and Archer Aviation Stocks - TipRanks
Finanzdaten der ARK Genomic Revolution ETF-Aktie (ARKG)
Es liegen keine Finanzdaten für ARK Genomic Revolution ETF (ARKG) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
Kapitalisierung:
|
Volumen (24h):